Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Isis claims oligonucleotides for diagnostic use

May 24, 1996

Ortho claims agents for osteoporosis

May 24, 1996

Role of DF3 in human carcinoma and potential therapeutics

May 24, 1996

Ajinomoto reports antitumor antibiotic

May 24, 1996

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

Schering-Plough claims antiherpesvirus agents

May 24, 1996

Wound-healing peptides claimed by Morinaga Milk

May 24, 1996

Akzo Nobel claims contraceptive vaccines

May 17, 1996

Yamanouchi claims antidiabetic agents

May 17, 1996

Zaprinast claimed for treatment of renal failure

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...